Ignite Creation Date:
2024-05-06 @ 1:05 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03920007
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-20
First Post:
2019-04-10
Brief Title:
Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
Sponsor:
Atsena Therapeutics Inc
Organization:
Atsena Therapeutics Inc
Organization Data
Organization:
Atsena Therapeutics Inc
Class:
INDUSTRY
Study ID:
ATSN-101-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Atsena Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None